The Patent Finder

Meiji Seika Pharma Co., Ltd.

37 patents currently held · Updated Nov 21, 2026
42 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

Previously recorded as Meiji Seika Kaisha, Ltd. (to 2011)

11
Ending by 2030
Dec 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 22, 2027
    The maintenance fee for Processes for preparing a diazabicyclooctane compound (US 11,731,971) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
  • 1 fee due May 10, 2027
    The maintenance fee for Beta-lactamase inhibitor and process for preparing the same (US 9,181,250) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
  • 1 fee due Aug 11, 2027
    The maintenance fee for Processes for preparing a diazabicyclooctane compound (US 10,556,905) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
  • 1 fee due Sep 30, 2027
    The maintenance fee for Processes for producing diazabicyclooctane compounds (US 10,604,522) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Effective aminoglycoside antibiotic for multidrug-resistant bacteria (US 10,617,704) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026
  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,257,955Endoglucanase Ppce and Cellulase Preparation Containing the Same
In force
 · High confidence
In forceHigh confidence
US 8,227,430Injectable, Injection Solution, and Injection Kit Preparation
In force
 · High confidence
In forceHigh confidence
US 8,383,392Transformant and Method for Production of Non-Natural Antibiotic
In force
 · High confidence
In forceHigh confidence
US 8,440,400Process for Amplifying DNA in Cells
In force
 · High confidence
In forceHigh confidence
US 8,569,033Surfactant Tolerant Cellulase and Method for Modification Thereof
In force
 · High confidence
In forceHigh confidence
US 8,975,053Thermostable Catalase
In force
 · High confidence
In forceHigh confidence
US 8,697,409Ketoreductase mutant
In force
 · USPTO record
In forceUSPTO record
US 10,774,318Novel Cellulase Gene
In force
 · High confidence
In forceHigh confidence
US 10,125,355Protein having B-glucosidase activity and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 8,975,057Novel Protein Having B-Glucosidase Activity and Uses Thereof
In force
 · High confidence
In forceHigh confidence
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
Also on record, not counted in the 37: 42 patents in force now held by others · 67 lapsed for an unpaid fee · 40 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 4 abandoned · 25 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited